Stocksigma LogoStocksigma Logo

Syngene International Q2 FY27 Financial Results and Operational Highlights

Syngene International reported Q2 FY27 revenue from operations of Rs 833 Cr, rising 13% QoQ but declining 9% YoY

Syngene International Q2 FY27 Financial Results and Operational Highlights

Syngene International Ltd 路 Investor Presentation 路 28 Oct 2026, 3:02 am

Syngene International Q2 FY27 Financial Results and Operational Highlights Syngene International reported Q2 FY27 revenue from operations of Rs 833 Cr, rising 13% QoQ but declining 9% YoY. Operating EBITDA margin stood at 18% (ex-forex hedge loss: mid-20s), while PAT before exceptional items was Rs 38 Cr, down 44% YoY. Reported PAT after exceptional items stood at Rs 32 Cr. For H1 FY27, revenue reached Rs 1,569 Cr, down 12% YoY. Operationally, Syngene signed its first manufacturing deal for the Bayview facility, secured new biologics supply contracts, and commissioned a Bengaluru Clinical Translational Sciences laboratory.

Original exchange filing (PDF)

More announcements from Syngene International Ltd

All Syngene International Ltd announcements